Document is current
Any future updates will be listed below
-
Authors
Mengel, David https://orcid.org/0000-0002-4133-7182
Soter, Ester
Ott, Julia Maren
Wacker, Madeleine
Leyva, Alejandra
Peters, Oliver
Hellmann-Regen, Julian https://orcid.org/0000-0003-0411-9204
Schneider, Luisa-Sophie https://orcid.org/0000-0001-5822-1744
Wang, Xiao
Priller, Josef
Spruth, Eike
Altenstein, Slawek
Schneider, Anja https://orcid.org/0000-0001-9540-8700
Fliessbach, Klaus
Wiltfang, Jens https://orcid.org/0000-0003-1492-5330
Hansen, Niels https://orcid.org/0000-0001-5785-9594
Rostamzadeh, Ayda
Düzel, Emra
Glanz, Wenzel
Incesoy, Enise I.
Buerger, Katharina
Janowitz, Daniel
Ewers, Michael https://orcid.org/0000-0001-5231-1714
Perneczky, Robert https://orcid.org/0000-0003-1981-7435
Rauchmann, Boris
Teipel, Stefan
Kilimann, Ingo
Laske, Christoph
Sodenkamp, Sebastian
Spottke, Annika
Brustkern, Johanna
Brosseron, Frederic https://orcid.org/0000-0003-3137-7516
Wagner, Michael
Stark, Melina
Kleineidam, Luca https://orcid.org/0009-0006-3309-6856
Shao, Kai
Lüsebrink, Falk
Yakupov, Renat https://orcid.org/0000-0002-3868-284X
Schmid, Matthias
Hetzer, Stefan
Dechent, Peter
Scheffler, Klaus
Berron, David https://orcid.org/0000-0003-1558-1883
Jessen, Frank
Synofzik, Matthis https://orcid.org/0000-0002-2280-7273
,
- License Information
-
More Information
Article History
Received: 26 July 2024
Revised: 10 March 2025
Accepted: 7 April 2025
First Online: 18 April 2025
Competing interests
: David Berron is a scientific co-founder of neotiv GmbH and owns company shares. Frank Jessen reports grant support from Roche and speaker and advisor honorarium from Abbvie, AC immune, Biogen, Eisai, Grifols, Janssen, Lilly, Novo Nordisk, Roche. Matthis Synofzik has received consultancy honoraria from Ionis, UCB, Prevail, Orphazyme, Servier, Reata, GenOrph, AviadoBio, Biohaven, Solaxa, Biogen, Zevra, and Lilly, all unrelated to the present manuscript. All other authors report no disclosures.
: All methods were performed in accordance with the relevant guidelines and regulations. The ethical committees of all participating centers approved the protocol. All participants provided informed consent prior to study participation. Data analysis was approved by the Ethics Committee of the Medical Faculty of the Eberhard Karls University and the University Hospital Tübingen (665/2021BO2).
: During the preparation of this work the authors used OpenAI (2024) ChatGPT (Version 4.0) in order to improve readability and language. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.
